To further examine the role of LAPTM4B in NPC cells, we designed siRNA (siLAPTM4B) to downregulate the endogenous levels of LAPTM4B in CNE-2 cells and knockdown efficiency was confirmed by Western blot. This evidence concerns the gene LAPTM4B and nasopharyngeal carcinoma.